<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1006</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2020-10-25-27</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Nebulized therapy in the COVID-19 era</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Shirokova</surname><given-names>Irina</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Prozherina</surname><given-names>Yuliya</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff id="aff-1">Remedium</aff><aff id="aff-2">RM Analytics</aff><pub-date date-type="epub" iso-8601-date="2020-12-10" publication-format="electronic"><day>10</day><month>12</month><year>2020</year></pub-date><issue>10</issue><fpage>25</fpage><lpage>27</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2020,</copyright-statement><copyright-year>2020</copyright-year></permissions><abstract>Nebulized therapy is one of the most reliable and affordable respiratory treatments for patients of all ages. Meanwhile, despite the clear advantages of nebulized therapy and the increasing recognition that it is gaining, serious disagreements have arisen concerning the feasibility of the use of nebulizers due to the risk of coronavirus infection during the COVID-19 pandemic. We tried to go further into the matter.</abstract><kwd-group xml:lang="en"><kwd>coronavirus</kwd><kwd>pandemic</kwd><kwd>nebulizers</kwd><kwd>filtration</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>коронавирус</kwd><kwd>пандемия</kwd><kwd>небулайзеры</kwd><kwd>фильтрация</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Терехова Е.П., Бодня О.С., Терехов Д.В., Ненашева Н.М. Возможности небулайзерной терапии бронхиальной астмы. Эффективная фармакотерапия. 2018;(6):30-39. Режим доступа: https://umedp.ru/ articles/vozmozhnosti_nebulayzernoy_terapii_bronkhialnoy_astmy_.html.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Бродская О.Н. Небулайзерная терапия при обструктивных заболеваниях легких: вчера, сегодня, завтра. Астма и аллергия. 2019;(3):22-28. Режим доступа: https://elibrary.ru/item.asp?id=41518877.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Бродская О.Н., Белевский А.С. План действий при обострении бронхиальной астмы. Практическая пульмонология. 2018;(2):100-105. Режим доступа: https://elibrary.ru/item.asp?id=36273095.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Ari A. Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19. Respir Med. 2020;167:105987. doi: 10.1016/j.rmed.2020.105987.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>MN Department of health. Aerosol-Generating Procedures and Patients with Suspected or Confirmed COVID-2020. Available at: https://www.health.state.mn.us/diseases/coronavirus/hcp/aerosol.pdf.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Пфайфер М., Эвиг С., Фосхаар Т. и др. Меморандум по практической реализации дифференцированной аппаратной терапии острой дыхательной недостаточности при COVID-19. Немецкое общество пульмонологии и респираторной медицины (DGP). (In Russ.) Available at: http://pari. com.ru/doc/Reprint_Memorandum_COVID-19_01.pdf.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Tashkin D.P., Barjaktarevic I.Z. Nebulized Treatments and the Possible Risk of Coronavirus Transmission: Where Is the Evidence? Chronic Obstr Pulm Dis. 2020;7(3):136-138. doi: 10.15326/jcopdf.7.3.2020.0161.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Thomas P., Baldwin C., Bissett B. et al. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J Physiother. 2020;66(2):73-82. doi: 10.1016/j.jphys.2020.03.011.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Небулайзеры PARI. Режим доступа: http://pari.com.ru/productsnebul.html.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Schuschnig U., Ledermüller R., Gramann J. Efficacy of the PARI filter-valve set to prevent environmental contamination with aerosol during nebulizer therapy. 2020. Available at: https://www.researchgate.net/publi- cation/342987954.</mixed-citation></ref></ref-list></back></article>
